Arcus Biosciences, Inc. (RCUS)
18.19
-0.42
(-2.26%)
USD |
NYSE |
Oct 30, 16:00
18.18
-0.02
(-0.08%)
After-Hours: 20:00
Arcus Biosciences Price : 18.19 for Oct. 30, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | 18.34 | 18.90 | 17.81 | 18.19 | 1.936M |
| Oct 29, 2026 | 18.62 | 19.02 | 18.12 | 18.61 | 1.666M |
| Oct 28, 2026 | 17.85 | 18.50 | 17.76 | 18.39 | 2.019M |
| Oct 27, 2026 | 17.62 | 18.33 | 17.53 | 18.14 | 2.232M |
| Oct 26, 2026 | 18.37 | 18.62 | 17.63 | 17.76 | 2.700M |
| Oct 23, 2026 | 19.02 | 19.09 | 18.43 | 18.54 | 5.925M |
| Oct 22, 2026 | 17.43 | 19.62 | 17.43 | 19.36 | 8.371M |
| Oct 21, 2026 | 24.47 | 24.47 | 18.98 | 19.10 | 4.654M |
| Oct 20, 2026 | 21.26 | 24.70 | 20.81 | 23.75 | 6.242M |
| Oct 19, 2026 | 22.44 | 22.94 | 21.37 | 22.14 | 3.517M |
| Oct 16, 2026 | 22.79 | 22.96 | 21.60 | 22.12 | 1.426M |
| Oct 15, 2026 | 22.53 | 23.28 | 22.53 | 22.82 | 1.210M |
| Oct 14, 2026 | 22.82 | 23.47 | 22.36 | 22.53 | 1.212M |
| Oct 13, 2026 | 23.87 | 24.00 | 22.46 | 22.51 | 1.394M |
| Oct 12, 2026 | 24.42 | 24.73 | 24.12 | 24.34 | 1.338M |
| Oct 09, 2026 | 23.89 | 24.58 | 23.75 | 24.41 | 795189.0 |
| Oct 08, 2026 | 24.29 | 24.38 | 22.80 | 23.83 | 1.865M |
| Oct 07, 2026 | 24.22 | 24.85 | 23.90 | 24.52 | 1.601M |
| Oct 06, 2026 | 24.96 | 24.96 | 23.96 | 24.28 | 824849.0 |
| Oct 05, 2026 | 24.19 | 24.95 | 24.10 | 24.74 | 1.391M |
| Oct 02, 2026 | 25.48 | 25.58 | 24.09 | 24.44 | 1.042M |
| Oct 01, 2026 | 25.86 | 26.26 | 25.13 | 25.23 | 1.363M |
| Sep 30, 2026 | 26.18 | 26.35 | 25.56 | 25.83 | 1.362M |
| Sep 29, 2026 | 24.93 | 26.04 | 24.76 | 25.65 | 1.253M |
| Sep 28, 2026 | 24.85 | 25.50 | 24.35 | 25.01 | 1.249M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Halozyme Therapeutics, Inc. | 130.91 |
| AVITA Medical, Inc. | 15.65 |
| Iovance Biotherapeutics, Inc. | 8.48 |
| Editas Medicine, Inc. | 2.67 |
| Recursion Pharmaceuticals, Inc. | 4.03 |
Price Related Metrics
| PS Ratio | 18.52 |
| PEG Ratio | -0.2011 |
| Price to Book Value | 4.979 |
| Earnings Yield | -21.46% |
| Market Cap | 2.310B |
| PEGY Ratio | -0.2011 |